Top compounds associated with response to RP11-729L2.2


Feature Type Standardized
Nominal ANOVA
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.072 0.04
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.16 0.05
mRNA PLX4720 CTRPv2 pan-cancer AAC -0.076 0.05
mRNA tandutinib CTRPv2 pan-cancer AAC 0.078 0.05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.05
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.079 0.05
mRNA narciclasine CTRPv2 pan-cancer AAC 0.07 0.05
mRNA skepinone-L CTRPv2 pan-cancer AAC 0.11 0.05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.05
mRNA ML203 CTRPv2 pan-cancer AAC 0.08 0.05
Download CSV